Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients read more 10/20/22
Mountain Group Partners Completes Fundraising on $128 Million MGP Venture Fund III read more 06/28/22
TARGAN Secures $35M Series C Financing Led by Mountain Group Partners and NovaQuest Capital Management to Commercialize Novel Vaccine Delivery System for Poultry Industry read more 05/25/22
MINDERA HEALTH™ LAUNCHES PILOT WITH NATIONAL HEALTH INSURANCE COMPANY TO IMPROVE MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS PATIENTS THROUGH PRECISION MEDICINE read more 04/28/22
PhaseBio reports full results of phase 2b trial of bentracimab to reverse ticagrelor’s antiplatelet activity read more 04/04/22
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis read more 03/28/22
